Sernova Biotherapeutics Inc Stock
Stocks
SVA
CA81752F1062
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
End-of-day quote
Toronto S.E.
2026-09-15
|
5-day change | 1st Jan Change | ||
| 0.1000 CAD | -9.09% |
|
-23.08% | -23.08% |
| Market Cap | 37.76M 27.13M 23.5M 22.23M 20.12M 2.6B 38.05M 265M 102M 1.32B 102M 99.67M 4.21B | P/E 2026 * |
-4x | P/E 2027 * | -3.33x |
|---|---|---|---|---|---|
| Enterprise Value | 37.76M 27.13M 23.5M 22.23M 20.12M 2.6B 38.05M 265M 102M 1.32B 102M 99.67M 4.21B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 7.55x |
| Free-Float |
89.49% | Yield 2026 * |
-
| Yield 2027 * | - |
Toronto S.E.CAD
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| SVA | End-of-day quote | |
Toronto S.E.
| SVA | Delayed | |
OTC Markets
| SEOVF | Delayed | |
Xetra
| PSH0 | Delayed | |
Tradegate
| PSH0 | Real-time | |
Deutsche Boerse AG
| PSH0 | Delayed | |
Börse Stuttgart
| PSH0 | Delayed | |
Boerse Muenchen
| PSH0 | Real-time |
| 1 day | -9.09% | ||
| 1 week | -23.08% | ||
| Current month | -9.09% | ||
| 1 month | -9.09% | ||
| 3 months | -35.48% | ||
| 6 months | -41.18% | ||
| Current year | -23.08% |
| 1 week | 0.1 | 0.15 | |
| 1 month | 0.1 | 0.15 | |
| Current year | 0.1 | 0.2 | |
| 1 year | 0.1 | 0.2 | |
| 3 years | 0.1 | 0.83 | |
| 5 years | 0.1 | 2.22 | |
| 10 years | 0.1 | 2.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Rigby
CEO | Chief Executive Officer | 58 | 2024-08-11 |
James Parsons
DFI | Director of Finance/CFO | 60 | 2024-10-10 |
David Burke
IRC | Investor Relations Contact | - | 2024-10-10 |
| Director | Title | Age | Since |
|---|---|---|---|
James Parsons
BRD | Director/Board Member | 60 | 2012-04-18 |
Steven Sangha
BRD | Director/Board Member | - | 2023-04-23 |
David Paterson
BRD | Director/Board Member | - | 2024-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/3/26 | Sell | Company | -115,000 | 0.0305% | ||
| 5/22/26 | Option | Chairman | 228,912 | 0.0658% | ||
| 5/22/26 | Option | Director | 260,000 | 0.0748% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -9.09% | -23.08% | -44.44% | -87.34% | 27.13M | ||
| -0.13% | +1.83% | -25.35% | -3.85% | 108B | ||
| -0.92% | +1.12% | -25.09% | -2.54% | 11.77B | ||
| +0.34% | -7.22% | +112.90% | +128.54% | 10.12B | ||
| -0.11% | -5.11% | -54.48% | -71.65% | 3.97B | ||
| -0.20% | -4.44% | -28.37% | +23.21% | 2.36B | ||
| +0.38% | +20.05% | -7.60% | -64.63% | 2.16B | ||
| -0.88% | -5.48% | - | - | 1.82B | ||
| +0.07% | -4.17% | -22.83% | -30.97% | 1.5B | ||
| Average | -1.17% | -2.68% | -11.91% | -13.65% | 15.74B | |
| Weighted average by Cap. | -0.16% | +1.08% | -15.91% | +3.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 5M 3.59M 3.11M 2.94M 2.66M 345M 5.04M 35.12M 13.51M 175M 13.5M 13.2M 557M |
| Net income | -11.3M -8.12M -7.03M -6.65M -6.02M -779M -11.39M -79.36M -30.53M -395M -30.5M -29.82M -1.26B | -13.9M -9.99M -8.65M -8.18M -7.41M -958M -14M -97.62M -37.56M -486M -37.52M -36.68M -1.55B |
| Net Debt | - | - |
Employees
8
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-15 | CA$0.1000 | -9.09% | 983,178 |
| 26-09-14 | CA$0.1100 | -18.52% | 1,227,009 |
| 26-09-11 | CA$0.1350 | -3.57% | 547,514 |
| 26-09-10 | CA$0.1400 | 0.00% | 500,864 |
| 26-09-09 | CA$0.1400 | +7.69% | 350,479 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.1000CAD
Average target price
1.000CAD
Spread / Average Target
+900.00%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SVA Stock
Select your edition
All financial news and data tailored to specific country editions

















